Latest news with #Burlingame
CBS News
09-08-2025
- CBS News
Crash in front of Burlingame business kills 4-year-old boy, injures 6-year-old girl
A 4-year-old boy was killed and another child was injured in Burlingame in a crash Friday evening, Burlingame Police said. The crash happened in front of a restaurant on the 1200 block of Donnelly Avenue, around 6:25 pm. Burlingame Police said the two children were on the sidewalk in front of a business when they were hit by a vehicle. The two children were identified as a 4-year-old boy and a 6-year-old girl. The boy died at the scene, and the girl was taken to the hospital. Police said the driver, a 19-year-old woman from San Mateo, stayed at the scene and cooperated with officers. Burlingame Police said the crash is under investigation
Yahoo
08-08-2025
- Business
- Yahoo
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032
Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032. The baculovirus expression system market is expanding steadily, driven by its growing use in producing recombinant proteins, vaccines, and gene therapy vectors due to its high expression efficiency and scalability. Rising demand for advanced biologics, increasing investment in vaccine development, and the surge in research for novel therapeutics are fueling market growth. Technological advancements, such as improved vector design and enhanced expression yields, are creating new opportunities for biopharmaceutical manufacturing. With expanding applications in cancer research, infectious disease treatment, and personalized medicine, the baculovirus expression system market offers significant demand opportunities in both research and commercial bioproduction sectors. Request Sample Copy: Global Baculovirus Expression System Market Key Takeaways According to Coherent Market Insights (CMI), the global baculovirus expression system market size is expected to reach USD 781.8 Mn by 2032, up from USD 436 Mn in 2025, registering a CAGR of 8.7%. Therapeutics remain the most lucrative application for baculovirus expression systems, accounting for 38% of the global market share in 2025. North America is set to dominate the industry, accounting for more than one-third of the global baculovirus expression system market share in 2025. Europe, with an estimated share of over one-fourth in 2025, is expected to remain the second-largest market for baculovirus expression system companies. Asia Pacific market is poised to record the fastest growth during the assessment period. Soaring Demand for Recombinant Proteins Propelling Market Growth Coherent Market Insights' latest baculovirus expression system market research report lists major factors driving industry growth. Increasing demand for recombinant proteins is one such growth driver. Recombinant proteins are witnessing high demand due to their broad application in therapeutic development, vaccine production, and biomedical research. They are becoming essential in drug discovery and disease treatment due to their ability to mimic natural proteins with high precision. Baculovirus expression systems (BES) are especially valued for their efficiency in producing complex recombinant proteins, especially eukaryotic proteins. As the demand for these sophisticated proteins rises, the need for advanced expression systems like baculovirus is expected to grow correspondingly, driving market growth. Purchase Now Up to 25% Discount on This Premium Report: High Production Costs and Adoption of Alternatives Hampering Market Growth The prospective baculovirus expression system market outlook looks promising, owing to rising demand for recombinant proteins. However, high production costs and competition for alternative expression systems present a significant barrier to widespread market expansion. Baculovirus expression system involves complex production processes and specialized infrastructure, leading to high operational costs. These factors limit its adoption and dampen overall baculovirus expression system market demand. Moreover, many pharmaceutical and biopharmaceutical companies opt for alternative expression systems like CHO cells, yeast, and E. coli as they are more established and cost-effective. This trend may further hinder baculovirus expression system market growth during the forecast period. Expanding Biopharmaceutical Industry Creating Lucrative Growth Opportunities The global biopharmaceutical sector is thriving as the need for vaccines, biologics, and gene therapies continues to rise. This trend is fueling demand for efficient and scalable expression systems like baculovirus, which are instrumental in recombinant protein production. As a result, significant growth opportunities are emerging for companies operating in this space. \Impact of AI on the Baculovirus Expression System Market Artificial Intelligence (AI) is positively impacting the baculovirus expression system (BEVS) market. It not only streamlines protein production processes but also improves overall efficiency. Researchers can optimize variables like cell density, media composition, and viral vector design by using AI-driven modeling and predictive analytics. These optimizations can lead to improved protein yields and faster development timelines. AI also supports real-time monitoring and automation in bioreactors, thereby reducing the need for manual intervention and minimizing contamination risks. These advancements are particularly valuable in the production of vaccines, gene therapies, and complex recombinant proteins. Advanced technologies like AI are making BEVS more scalable and cost-effective. They are accelerating its adoption across pharmaceutical and biotechnology sectors, thereby supporting expansion of the baculovirus expression system industry. Emerging Baculovirus Expression System Market Trends Rising preference for baculovirus expression systems in biopharmaceutical production and vaccine development is a key growth-shaping trend. Baculovirus systems are particularly valued for their scalability, safety, and ability to produce complex proteins, including virus-like particles (VLPs) and subunit vaccines (e.g., for COVID-19). Increasing demand for gene and cell therapies is driving interest in baculovirus expression systems. Baculovirus vectors are being investigated for gene delivery applications and show potential in the development of engineered cell therapies, including experimental CAR-T platforms. Growing trend of outsourcing is positively influencing the baculovirus expression system market value. Biotech and pharmaceutical companies are increasingly partnering with CDMOs that specialize in baculovirus-based protein production to streamline operations and reduce costs. Escalating demand for biosimilars is driving interest in alternative expression platforms, including baculovirus expression systems. These systems are used by pharmaceutical and biopharmaceutical companies for the efficient and cost-effective production of certain biosimilar proteins, particularly where complex mammalian glycosylation is not essential. Advancements in genetic engineering and biotechnology are further boosting market growth. Recent innovations like improved baculovirus vectors, optimized host cell lines, and refined expression technologies have significantly enhanced recombinant protein yield and quality. Similarly, gene-editing tools like CRISPR are being explored to modify host cells or viral genomes, expanding the potential of baculovirus systems in research and biopharmaceutical production. Request For Customization: Analyst's View said senior analyst Abhijeet Kale. Current Events and Their Impact on the Baculovirus Expression System Market Event Description and Impact Emerging RSV and Influenza Vaccine Pipelines (2024–2025) Description: Biopharma companies like Novavax and Sanofi are expanding their recombinant protein-based vaccine pipelines post-COVID, especially for RSV and influenza. Impact: This leads to increased reliance on baculovirus platforms for scalable antigen production due to their proven safety, rapid expression timeline, and cost-effectiveness. Novavax's use of BEVS (baculovirus expression vector system) for its RSV vaccine further validates this trend. CRISPR and Gene Editing Advancements in Insect Cell Lines Description: Enhanced cell lines like Sf9 and Hi5 are being engineered using CRISPR to increase yield and stability of expressed proteins. Impact: These improvements are reducing production costs and turnaround time, making baculovirus systems more competitive for monoclonal antibody and enzyme production. AI in Biomanufacturing (2024) Description: Companies are applying AI to optimize expression parameters in insect cell cultures. Impact: AI-driven process development is improving consistency and yield in baculovirus-based manufacturing, making them more attractive for precision biologics and personalized therapies. Competitor InsightsKey companies in baculovirus expression system market report: Merck KGaA Thermo Fisher Scientific Takara Bio Oxford Expression Technologies Qiagen N.V. Agilent Technologies Bio-Rad Laboratories Promega Corporation New England Biolabs Syngene International Limited Sartorius AG Genscript Biotech Corporation Absolute Antibody Creative Biogene Aragen Bioscience Vivopure Rockland Immunochemicals Virovek Proteogenix Protein Technologies, Inc. (PTI) Key Developments In April 2025, Qiagen expanded its digital PCR portfolio with the launch of new Lentivirus solutions to strengthen gene and cell therapy quality control. This highlights the company's commitment to help accelerate the development of safe and effective biotherapeutics. In April 2024, Expression Systems collaborated with Thomson to demonstrate how the combination of its ESF AdvanCD™ cell culture medium and Thomson Optimum Growth® flasks offers an effective solution for scaling up protein production using baculovirus and insect cell expression systems. Global Baculovirus Expression System Market Segmentation: By Product TypeBaculovirusExpression VectorReagentsOthersBy ApplicationTherapeuticsVaccinesProtein PurificationOthersBy End UserBiopharmaceutical CompaniesResearch InstitutesOthersBy RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaRead More ReportsCell-Free Protein Expression Market Size, Share & Trend Analysis Report for 2025-2032Recombinant Protein Market Analysis and Forecast for 2025-2032Protein Expression Systems Market Size, Share, Trends & Opportunities for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-08-2025
- Business
- Yahoo
Medical Technology Platform Market Poised for Significant Growth, Forecast to Hit USD 67.26 Billion by 2032, Says Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Medical Technology Platform Market is estimated to be valued at USD 31.59 Bn in 2025 and is expected to reach USD 67.26 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The medical technology platform market is experiencing rapid growth, driven by the integration of advanced technologies such as artificial intelligence, cloud computing, Internet of Medical Things (IoMT), and big data analytics. These platforms enable seamless healthcare delivery through telemedicine, remote patient monitoring, diagnostics, and personalized treatment solutions. Trends such as interoperability, predictive analytics for disease management, and patient-centric digital ecosystems are reshaping the healthcare landscape. Rising demand for connected, data-driven care, coupled with regulatory support and the push for value-based healthcare, is positioning the medical technology platform market as a key driver of future medical innovation and efficiency. Request Sample Copy: Global Medical Technology Platform Market Key Takeaways According to Coherent Market Insights (CMI), the global medical technology platform market size is expected to grow more than 2.1X during the forecast period, increasing from USD 31.59 Bn in 2025 to USD 67.26 Bn by 2032. Global demand for medical technology platforms is projected to rise at a CAGR of 11.4% during the assessment period. Cardiovascular segment is set to remain the most lucrative application area for medical technology platforms, capturing a prominent 23% market share in 2025 North America is likely to maintain its dominant position during the assessment period, accounting for over two-fifths of the global medical technology market share in 2025. Europe is poised to remain the second-leading market for medical technology platforms, capturing a global market share of 28.8% in 2025. Asia Pacific is anticipated to emerge as a hotbed for medical technology platform companies during the assessment period. Rising Demand for Digital Healthcare Solutions Spurring Market Growth Coherent Market Insights' latest medical technology market analysis outlines key factors driving industry growth. Increasing demand for digital healthcare solutions is one such growth driver. Patients and healthcare providers in the contemporary world demand seamless digital experiences. This is driving adoption of telemedicine, remote monitoring, and mobile health apps, thereby fostering growth of the medical technology platform market. There is also an increasing need for interoperability across healthcare systems. This trend is fueling adoption of medical technology platforms that consolidate electronic health records (EHRs), diagnostics, imaging, and telemedicine. Purchase Now Up to 25% Discount on This Premium Report: High Cost and Data Security Concerns Restraining Market Growth The future medical technology platform market outlook appears promising. However, high cost of medical devices and growing concerns over data security may limit market growth to some extent during the forecast period. Advanced medical technologies like robotic surgical systems, implantable devices, and imaging tools are quite expensive. This cost factor deters their adoption, leading to reduced medical technology platform market demand. Moreover, growing digitalization of healthcare raises risks of cyberattacks and data breaches. These security concerns might also limit adoption during the forthcoming period, potentially restricting the medical technology platform market growth. Rising Incidence of Chronic Diseases Creating Lucrative Growth Opportunities The global incidence of chronic conditions like diabetes, cancer, cardiovascular diseases, and neurological disorders is steadily increasing. This growing burden is expected to drive demand for advanced diagnostic, monitoring, and therapeutic platforms, thereby creating significant growth opportunities in the medical technology platform industry. There is also increasing demand for improved patient care, including earlier and more accurate diagnosis, personalized treatments, and better recovery outcomes. This is fueling need for medical technology platforms, as they support these goals by providing advanced tools for monitoring, diagnosis, and intervention. Impact of AI on the Medical Technology Platform Market Artificial Intelligence (AI) is becoming a powerful tool in the medical technology platform market. It enhances diagnostic accuracy, optimizes clinical workflows, and enables predictive analytics. AI-powered platforms are revolutionizing areas like imaging, patient monitoring, and personalized treatment planning by delivering faster, data-driven insights. These innovations improve operational efficiency, reduce human error, and support real-time decision-making, ultimately driving better patient outcomes. Companies like Medtronic, GE Healthcare, and Philips lead from the forefront when it comes to AI adoption. For instance, in April 2024, Medtronic launched 14 new AI‑driven algorithms for its Touch Surgery™ Performance Insights platform. These algorithms span surgical workflow optimization, instrument recognition, and anatomical structure detection, enhancing AI-powered post‑operative analysis for various procedures. Emerging Medical Technology Platform Market Trends Expansion of telehealth and remote patient monitoring is a key growth-shaping trend in the medical technology platform market. The COVID-19 pandemic significantly accelerated the adoption of remote healthcare services. This shift has increased the demand for robust, interoperable, and scalable medical technology platforms that can support virtual consultations, real-time health monitoring, and data integration. Another notable trend is the growing demand for personalized medicine. Medical technology platforms support this shift by enabling genomic data analysis, personalized treatment planning, and biomarker discovery, which are essential components of precision medicine. There is a growing shift towards preventive care and home-based healthcare. This trend is fueling demand for at-home diagnostic tools, wearable health devices, and remote patient monitoring solutions that support proactive and continuous health management. Governments and regulatory bodies across different regions are promoting or mandating the use of electronic health records (EHRs). This is expected to create a fertile ground for the growth of medical technology platform industry during the forecast period. Ongoing technological advancements are driving the popularity and adoption of medical technology platforms. Companies are increasingly integrating AI and machine learning (ML) into these platforms to enhance diagnostics, enable predictive analytics, and support personalized treatment, thereby fueling market growth. Request For Customization: Analyst's View said Komal Dighe, a senior analyst at CMI. Current Events and Their Impact on the Medical Technology Platform Market Event Description and Impact Generative & Clinical AI Expanding Inside Healthcare Platforms Description: Cedars‑Sinai Connect, launched in collaboration with K Health, has served over 42,000 patients, automating intake, preliminary diagnosis, and triage via chatbot interfaces, delivering AI recommendations rated optimal ~77% of the time versus 67% for physicians. Impact: This highlights the strong demand for tightly integrated AI capabilities in diagnostics, patient intake, and automated documentation. Remote Monitoring, Digital Twin & IoMT Integration Description: At SGPGI in India, digital twin tools powered by AI are being used to simulate and optimize surgical outcomes using patient-specific hemodynamic data, pioneering safer, personalized care in a resource‑stretched setting. Impact: This highlights a need for platforms that can integrate IoMT wearables, support real-time data modeling, and simulate outcomes via interoperable digital twin frameworks. Healthcare Cyberattacks & Zero‑Trust Driving Security‑First Platforms Description: The healthcare sector saw a staggering 1,710 security incidents in 2025. Impact: There is an increasing pressure to adopt zero-trust architectures, end-to-end encryption, and resilient backup systems within medtech platforms. Competitor InsightsKey companies in the medical technology platform market research report: GE Healthcare Philips Medtronic Stryker Canon Medical Systems Abbott Siemens Healthineers Boston Scientific Baxter Johnson & Johnson Key Developments In April 2025, Royal Philips unveiled its new groundbreaking Elevate Platform upgrade on the EPIQ Elite ultrasound imaging platform. This new solution is designed to address the growing demand for greater diagnostic efficiency and streamlined workflows. In April 2025, SPARK Radiology launched a new AI-powered technology platform named in India. The platform is specifically developed to streamline radiology reporting workflows, reduce manual workload, enable faster report turnaround times, and ultimately support more accurate and timely diagnoses. In September 2024, Huawei launched the 'Medical Technology Digitalization 2.0 Solution' during its HUAWEI CONNECT 2024 event in Shanghai. The solution utilizes AI-assisted diagnosis and intelligent quality control, with dual goals of facilitating precision healthcare and supporting hierarchical diagnosis and treatment systems. Market Segmentation:Medical Technology Market, By Product TypeDiagnostic PlatformsMonitoring PlatformsSurgical PlatformsImplantable Devices PlatformsOthersMedical Technology Market, By ApplicationCardiovascularOrthopedicsNeurologyRespiratoryOncologyOthersMedical Technology Market, By End UserHospitalsClinicsDiagnostic CentersAmbulatory Surgical CentersOthersMedical Technology Market, By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa Read More Reports:Digital Medicines Market Size, Share & Trend Analysis Report for 2025-2032Integrated Patient Care Systems Market Size, Share, Trends & Opportunities for 2025-2032Digital Health Monitoring Devices Market Analysis and Forecast for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | TwitterSign in to access your portfolio
Globe and Mail
14-07-2025
- Business
- Globe and Mail
Piper Sandler Expands Technology Investment Banking Team with the Addition of Anson Tsai
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Anson Tsai as a managing director to its technology investment banking team. He will be based in the Burlingame office. 'We are excited to welcome Anson to Piper Sandler. Anson's sector experience and deep client relationships will have an immediate impact on our fast-growing team. We look forward to seeing his contributions to the firm and our clients,' said Steven Schmidt, co-head of technology investment banking at Piper Sandler. Prior to joining the firm, Tsai spent ten years with Bank of America Securities on their technology investment banking team. He focused on front-office software coverage, sourcing and executing M&A, IPO, equity and debt financing transactions for both public and private software companies. Before investment banking, he spent nearly eight years in front-office related roles, including sales and marketing management consulting, e-commerce marketing and business development, and event management and marketing. Tsai received a bachelor's degree in electrical engineering and computer sciences from the University of California at Berkeley and earned his Master of Business Administration degree from Cornell University. 'Anson is highly respected across the industry and brings with him tremendous expertise. During his career, Anson has advised on some of the industry's most strategic transactions across the front-office software space. His wealth of knowledge and significant experience will allow us to better serve our clients,' said Brian White, co-head of technology investment banking at Piper Sandler. ABOUT PIPER SANDLER Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.
Yahoo
14-07-2025
- Business
- Yahoo
Blood Flow Measurement Devices Market to Surpass USD 1,652.1 Million by 2032, Driven by Rising Demand for Non-Invasive Diagnostics
Burlingame, CA, July 14, 2025 (GLOBE NEWSWIRE) -- The global Blood Flow Measurement Devices Market is estimated to be valued at USD 886.0 Mn in 2025 and is expected to reach USD 1,652.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032. The demand for blood flow measurement devices is projected to rise steadily, driven by several key factors. These include a growing elderly population, an increasing prevalence of cardiovascular diseases, and a rising preference for minimally invasive surgical procedures. Technological advancements particularly in Doppler ultrasound systems are enhancing the accuracy and efficiency of blood flow detection and analysis, further propelling market expansion. However, the high cost of these advanced devices may pose a challenge and potentially limit broader adoption. Request Sample Report: Global Blood Flow Measurement Devices Market Key Takeaways According to Coherent Market Insights (CMI), the global blood flow measurement devices market size is expected to grow significantly during the forecast period, reaching USD 886 Mn in 2025 and USD 1,652.1 Mn by 2032. Global demand for blood flow measurement devices is projected to increase at a CAGR of 9.3% between 2025 and 2032. Laser Doppler blood flowmeters are expected to remain the top-selling product type, generating market revenue of about USD 314.5 Mn in 2025. Based on application, cardiovascular disease segment is expected to account for 45.5% of the global blood flow measurement devices market share in 2025. North America is set to remain the undisputed leader in the blood flow measurement devices industry, accounting for more than two-fifths of the global market share in 2025 Asia Pacific is expected to emerge as a hotbed for blood flood measurement device manufacturers during the assessment period. This is due to rising incidence of cardiovascular diseases and favorable government support. Rising Chronic Disease Burden Spurring Market Growth Coherent Market Insights' latest blood flow measurement devices market analysis offers insights into major factors driving industry growth. One such prominent growth driver is the increasing incidence of chronic diseases. Growing prevalence of cardiovascular and peripheral vascular diseases like atherosclerosis and hypertension is significantly driving demand for blood flow measurement devices. These devices enable real-time monitoring of blood circulation, which is essential for early detection, diagnosis, and timely medical intervention. Immediate Delivery Available | Buy This Premium Research Report: High Cost of Advanced Devices Limiting Market Growth The future blood flow measurement devices market outlook appears optimistic. However, high cost of advanced blood flow measurement devices is a significant barrier to widespread market expansion. Cutting-edge blood flow measurement systems like Doppler and electromagnetic flowmeters are quite expensive. This high cost deters small and medium-sized hospitals and clinics from adopting these technologies, leading to reduced overall blood flow measurement devices market demand. Rising Preference for Non-Invasive Diagnostic Tools Creating Growth Opportunities There is a growing preference for non-invasive and painless methods for measuring blood flow in the modern world. This is expected to uplift demand for advanced blood flow measurement devices, opening lucrative growth prospects for industry players. Increasing geriatric population is also creating growth opportunities for manufacturers of blood flow measurement devices. This is because elderly people are more susceptible to vascular disorders and diabetes, which require blood flow assessments. Impact of AI on the Blood Flow Measurement Devices Market Artificial Intelligence (AI) is becoming a powerful tool in the blood flow measurement devices market. It significantly enhances diagnostic precision, enables real-time monitoring, and expands these tools into wearable and telehealth applications. Advanced analytics powered by AI and machine learning help detect subtle changes in blood flow that human observers might miss. This results in improved accuracy and predictiveness. IoT and cloud integration enable remote monitoring and timely clinician alerts for vascular issues. Key players are developing smart ultrasound and PPG systems with edge AI for cuffless, low-power measurements in wearables and point-of-care devices. Emerging Blood Flow Measurement Devices Market Trends Technological advancements in blood flow measurement systems are breathing new life into the market. Companies are constantly developing advanced Doppler ultrasound and electromagnetic blood flowmeters to improve accuracy, sensitivity, and efficiency of diagnostic procedures. Portable and wearable blood flow measurement devices are gaining immense traction in clinical and homecare settings. Rising adoption of these compact and user-friendly solutions is expected to foster growth of the blood flow measurement devices market in the coming years. Increasing number of surgical and diagnostic procedures is also contributing to rising sales of blood flow measurement devices. These devices are being widely used for blood flow monitoring during vascular surgeries, organ transplants, and reconstructive procedures for better outcomes. Growing number of surgical and diagnostic procedures is contributing to rising sales of blood flow measurement devices. These devices are increasingly used during vascular surgeries, organ transplants, and reconstructive procedures to monitor blood flow and ensure optimal patient outcomes. Request for Customization: Analyst's View said senior analyst Komal Dighe. Current Events and Their Impact on the Blood Flow Measurement Devices Market Event Description and Impact Rising Cardiovascular Complications Linked to Long COVID and Post-COVID Conditions Description: Recent studies highlight a significant increase in vascular complications in post-COVID patients, especially microvascular dysfunction. Impact: This is pushing hospitals and research centers to invest in advanced blood flow measurement tools like laser Doppler and perfusion imaging to track subtle circulatory anomalies in recovering patients. AI Integration in Hemodynamic Monitoring Devices Description: Leading blood flow measurement device companies are launching AI-enabled Doppler and transit-time flow meters that automatically interpret flow data and flag anomalies in real time. Impact: These innovations are reducing clinician burden and enhancing early diagnosis, leading to faster adoption in both high-end hospitals and outpatient care settings. Regulatory Approvals and Reimbursements Description: Recent FDA and CE approvals for innovative blood flow measurement systems (e.g., laser Doppler flowmetry, transit-time flow meters) improve market trust. Impact: Such approvals strengthen commercialization prospects and encourage new product launches by key market players. Competitor InsightsKey companies listed in the blood flow measurement devices market report include: Medistim ASA Cook Medical Inc. Perimed AB Transonic Systems Inc. Atys Medical Getinge Group Deltex Medical Group PLC Biopac Systems Inc. ADInstruments Fluke Biomedical Compumedics Moor Instruments Ltd. ArjoHuntleigh Inc. SONOTEC GmbH NDS Surgical Imaging Cheetah Medical Koven Technology D.E. Hokie & Associates Nihon Kohden Corporation GSI Group Key Developments In July 2024, Getinge introduced Pulsiocare, a cutting-edge hemodynamic monitoring platform built on its award-winning standard user interface. The new advanced device offers a modern and intuitive-to-use platform for hemodynamic assessment and patient monitoring. In October 2024, Researchers at the California Institute created a laser-based, head‑worn device that noninvasively monitors cerebral blood flow and volume using speckle contrast optical spectroscopy (SCOS). This novel device offers a direct method of assessing stroke risk based on physiological markers. Market Segmentation: By Product Type Laser Doppler Blood Flowmeters Ultrasonic Doppler Blood Flowmeters Electromagnetic Blood Flowmeters By Application Cardiovascular Disease Tumor Monitoring Gastroenterology Diabetes Dermatology Others By End User Hospital Clinics Ambulatory Surgical Centers Specialty Centers Others Region: North America Europe Asia Pacific Latin America Middle East Africa Read More Report:Blood Clot Retrieval Devices Market Analysis and Forecast for 2025-2032Blood Glucose Monitoring Market Size, Share & Trend Analysis Report for 2025-2032Blood Pressure Monitoring Devices Market Size, Share, Trends & Opportunities for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | Twitter
